Related Experiment Video
Updated: Apr 30, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Glucocorticoid receptor β stimulates Akt1 growth pathway by attenuation of PTEN
Lance A Stechschulte1, Leah Wuescher2, Joseph S Marino3
1From the Center for Hypertension and Personalized Medicine, Department of Physiology and Pharmacology and.
Abstract:
Glucocorticoids (GCs) are known inhibitors of proliferation and are commonly prescribed to cancer patients to inhibit tumor growth and induce apoptosis via the glucocorticoid receptor (GR). Because of alternative splicing, the GR exists as two isoforms, GRα and GRβ. The growth inhibitory actions of GCs are mediated via GRα, a hormone-induced transcription factor. The GRβ isoform, however, lacks helix 12 of the ligand-binding domain and cannot bind GCs. While we have previously shown that GRβ mRNA is responsive to insulin, the role of GRβ in insulin signaling and growth pathways is unknown. In the present study, we show that GRβ suppresses PTEN expression, leading to enhanced insulin-stimulated growth. These characteristics were independent of the inhibitory qualities that have been reported for GRβ on GRα. Additionally, we found that GRβ increased phosphorylation of Akt basally, which was further amplified following insulin treatment. In particular, GRβ specifically targets Akt1 in growth pathways. Our results demonstrate that the GRβ/Akt1 axis is a major player in insulin-stimulated growth.
Insights
Glucocorticoid receptor beta (GRβ) suppresses PTEN, enhancing insulin-stimulated growth by activating Akt1. This GRβ/Akt1 pathway promotes tumor growth independently of GRα.
Area of Science:
- Endocrinology
- Molecular Biology
- Cancer Research
Background:
- Glucocorticoids (GCs) inhibit proliferation and induce apoptosis via the glucocorticoid receptor (GR).
- The GR gene yields two isoforms: GRα (mediates GC effects) and GRβ (ligand-binding deficient).
- GRβ's role in insulin signaling and growth pathways remained unclear.
Purpose of the Study:
- To investigate the role of GRβ in insulin signaling and cellular growth.
- To elucidate the molecular mechanisms by which GRβ influences growth pathways.
Main Methods:
- Investigated GRβ's effect on PTEN expression.
- Assessed GRβ's impact on insulin-stimulated Akt phosphorylation.
- Determined GRβ's specific interactions within growth signaling pathways.
Main Results:
- GRβ was found to suppress PTEN expression, leading to enhanced insulin-stimulated growth.
- GRβ increased basal Akt phosphorylation, further amplified by insulin, specifically targeting Akt1.
- These effects were independent of GRβ's known inhibitory actions on GRα.
Conclusions:
- The GRβ/Akt1 axis is a significant mediator of insulin-stimulated growth.
- GRβ promotes tumor growth by modulating the PTEN/Akt1 pathway.
- Targeting the GRβ/Akt1 axis may offer novel therapeutic strategies in cancer treatment.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
TGF - β Signaling Pathway
Amplifying Signals via Enzymatic Cascade
GPCRs Regulate Adenylyl Cylase Activity
cAMP-dependent Protein Kinase Pathways
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
